New rare disease drug launches

Rund zwei Drittel (25 Medikamente) der neu eingeführten Medikamente haben eine seltene Erkrankung als Anwendungsgebiet ‒ es leiden daran also nicht mehr als fünf von 10.000 EU-Bürger:innen.

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

VFA. (2025). Neue Medikamente in Deutschland: Innovationsbilanz 2025. Retrieved September 17, 2026, from https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Via StatOrigin, https://statorigin.org/stat/stat_MR654CEM46NRJD4PSHSWXH43S3

Copy

MLA

VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025, https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MR654CEM46NRJD4PSHSWXH43S3.

Copy

Chicago

VFA. "Neue Medikamente in Deutschland: Innovationsbilanz 2025." 2025. https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MR654CEM46NRJD4PSHSWXH43S3.

Copy

BibTeX

@misc{vfa2025rarexh43s3, author = {{VFA}}, title = {Neue Medikamente in Deutschland: Innovationsbilanz 2025}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MR654CEM46NRJD4PSHSWXH43S3}, note = {Original source: https://www.vfa.de/de/forschung-entwicklung/meilensteine-und-neueinfuehrungen/innovationsbilanz-2025. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_MR654CEM46NRJD4PSHSWXH43S3.